Biden administration wants Medicare, Medicaid to cover obesity drugs
Move would also ensure access to the medications for approximately 4 million adult Medicaid enrollees.
Move would also ensure access to the medications for approximately 4 million adult Medicaid enrollees.
13 executives are stepping into new or expanded roles.
Seasonal shoppers focus on deals to make the most of every festive dollar this season.
The partnership will focus on supporting family caregivers with loved ones managing incontinence.
Nature’s Truth also remains the top brand in the independent pharmacy subcategories of single-letter vitamins; herbals and botanicals; specialty supplements; and mineral supplements, increasing its share in all four.
Chain Drug Review and Kearney hosted their third annual Health Equity Summit in Chicago, where a panel of experts discussed the prevalence of pharmacy deserts, affecting millions of Americans, and strategies to address these disparities.
BridgeBio Pharma has received FDA approval for a new drug for a rare heart disease after very promising trials.
Governor Kathy Hochul announced new regulations to govern Pharmacy Benefit Managers in New York. They aim to reduce prescription drug costs, increase transparency, and support small, independent pharmacies.
She succeeds Stuart Aitken, who will step down from his role as senior vice president and chief merchandising and marketing officer at the end of the year.
Johnson & Johnson has submitted an FDA application for the first subcutaneous IL-23 inhibitor for ulcerative colitis. This drug could offer patients a groundbreaking at-home treatment option.
Meijer honored exceptional team members with its 2024 Legacy Awards, recognizing individuals who embody the company’s core values of leadership, innovation, and service. Regional Vice President Maureen Mitchell received the prestigious Fred Meijer Award.
A recent NACDS poll highlights strong voter support for PBM reform and the significant influence healthcare issues had on voters' decisions in the 2024 elections.
This is the latest move in a bitter legal fight between the three largest pharmacy benefit managers, or PBMs, in the U.S. and the FTC.
The latest Factbook reveals that approximately 95 percent of all pharmaceutical sales moved through the traditional distribution segment in 2023, among other key findings.
The announcement was made by CEO Kevin Murphy, who highlighted Stalbaum’s extensive experience and contributions to the company since joining in 2019.